The cynic in me suspects that the way Chinese pharma and hospital relationships incentivize certain medications and tx plays a role in this. Methylpresnisolone has an interesting (not in a good way...) history in China, dating from its introduction only about 20-25 years ago.Originally Posted by ccmdfd
While the situation is much better than it was 10 years ago, the scope and prevalence of inherent venality among senior management at medical institutions in China would still be staggering to most Western observers. Think of the ethics of the shadiest strip mall "pain clinic" operator and scale that up to the head of a 1,000 bed hospital. Every Chinese clinician I know looks up to Western hospitals in this regard, even the ones who have seen the flaws in US, UK, Canadian, etc. medical centres up close. As might be expected, those on the front lines are usually focused on the right things, but the level of frustration and disillusionment they have to deal with as a result of the people running things is heartbreaking at times.
Reply With Quote
